National Medical Products Administration
In research, National Medical Products Administration stands highest in Life Sciences (#1,469 of 7,800 worldwide), Medicine (#2,537 of 10,443 worldwide) and Health Sciences (#3,168 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #3,311 of 28,054 · #8,242 all time
- Rank in China
- #815 of 3,058
- Research works
- 1.8k ▲ 124% vs 2013–17
- Citations
- 14k 8.2 per fractional work
- Top-10% rate
- 23.1% record average 16.5%
- Open access
- 30% world 28%
What is National Medical Products Administration known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,469 of 7,800 | 27.0% | 176 | #4099 | |
| MedicineField | #2,537 of 10,443 | 22.0% | 249 | #6560 | |
| Health SciencesDomain | #3,168 of 11,982 | 21.6% | 273 | #6675 | |
| Physical SciencesDomain | #6,280 of 12,888 | 18.5% | 129 | #10339 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,936 of 3,579 | 25.4% | 100 | #5150 | |
| Molecular BiologySubfield | #1,379 of 2,175 | 25.3% | 68 | #3600 |
Each strip is that field’s whole ranked pool, with the notch where National Medical Products Administration sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#4,099 #1,469
- Medicine#6,560 #2,537
- Health Sciences#6,675 #3,168
- Physical Sciences#10,339 #6,280
- Biochemistry, Genetics and Molecular Biology#5,150 #1,936
- Molecular Biology#3,600 #1,379
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 6.8×
- Immunology and Microbiology 3.8×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Chemistry 2.9×
- Medicine 2.2×
- Dentistry 2.0×
- Neuroscience 1.6×
- Veterinary 1.4×
- Nursing 1.1×
- Materials Science 1.0×
- Health Professions 0.8×
- Agricultural and Biological Sciences 0.8×
- Economics, Econometrics and Finance 0.8×
- Engineering 0.7×
- Mathematics 0.5×
- Chemical Engineering 0.3×
- Decision Sciences 0.3×
- Environmental Science 0.2×
- Computer Science 0.2×
- Energy 0.1×
- Psychology 0.1×
- Physics and Astronomy 0.1×
- Business, Management and Accounting 0.1×
- Earth and Planetary Sciences 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.0×
Who are the top researchers at National Medical Products Administration?
Ranked on the composite score, Li Zhang lead among researchers whose main affiliation is National Medical Products Administration.
- 1 Li Zhang China · #737,212 worldwide 7 citations · 26 works
Which keywords describe research at National Medical Products Administration?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Regenerative Medicine, Traditional Chinese Medicine, Epidemiology, Clinical Trials, Angiogenesis and Biomedical Applications.
- Syndrome Differentiation
- Direct-to-Consumer Marketing
- Translational Research
- Monoclonal Antibodies
- Phytochemistry
- Integrative Medicine
- Genomic Analysis
- Cancer Treatment
- Pathogenesis
- Targeted Therapy
- Metabolism
- Angiogenesis
- Drug Delivery
- Tumor Microenvironment
- Tissue Engineering
- Traditional Chinese Medicine
- Regenerative Medicine
- Clinical Trials
- Oxidative Stress
- Epidemiology
- Cancer
- Inflammation
- Biomedical Applications
- Antioxidant
- Biomarkers
- Nanoparticles
- Precision Medicine
- Immunity
- Immunotherapy
- Cancer Therapy
- Anti-inflammatory
- Vaccine
- PET Imaging
- Pharmacokinetics
- SARS-CoV-2
- Patient Safety
- Ethical Issues
- Regulatory Challenges
- Ayurveda
- Stem Cell Regulation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer37▲ 4.6×48 topics
- Epidemiology36▲ 1.53×85 topics
- Inflammation34▲ 2.7×75 topics
- Oxidative Stress23▲ 2.4×50 topics
- Biomedical Applications22▲ 3.1×27 topics
- Clinical Trials19▲ 4.8×16 topics
- Antioxidant18▲ 4.4×37 topics
- Regenerative Medicine18▲ 12×6 topics
- Biomarkers17▲ 4.1×16 topics
- Traditional Chinese Medicine16▲ 23×5 topics
- Nanoparticles16▲ 2.2×21 topics
- Tissue Engineering16▲ 4.3×13 topics
- Precision Medicine15▲ 5.5×7 topics
- Tumor Microenvironment15▲ 5.7×8 topics
- Immunity15▲ 6.1×9 topics
- Drug Delivery15▲ 4.5×13 topics
- Immunotherapy15▲ 3.4×18 topics
- Angiogenesis14▲ 7.4×15 topics
- Cancer Therapy14▲ 4.2×18 topics
- Metabolism13▲ 4.2×27 topics
- Anti-inflammatory12▲ 7.5×23 topics
- Targeted Therapy12▲ 8.9×5 topics
- Vaccine12▲ 4.9×10 topics
- Pathogenesis12▲ 3.8×21 topics
- PET Imaging11▲ 11×4 topics
- Cancer Treatment10▲ 7.0×9 topics
- Pharmacokinetics10▲ 6.2×10 topics
- Genomic Analysis9▲ 6.3×11 topics
- SARS-CoV-29▲ 4.8×5 topics
- Integrative Medicine9▲ 26×2 topics
- Patient Safety8▲ 9.6×2 topics
- Phytochemistry8▲ 11×7 topics
- Ethical Issues8▲ 13×2 topics
- Monoclonal Antibodies8▲ 15×3 topics
- Regulatory Challenges8▲ 15×2 topics
- Translational Research8▲ 37×2 topics
- Ayurveda8▲ 54×1 topic
- Direct-to-Consumer Marketing8▲ 58×1 topic
- Stem Cell Regulation8▲ 58×1 topic
- Syndrome Differentiation8▲ 54×1 topic
Which research topics does National Medical Products Administration publish most on?
By volume in 2022–2025: Biomedical Ethics and Regulation, Traditional Chinese Medicine Studies, Quality and Safety in Healthcare and Radiopharmaceutical Chemistry and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Biomedical Ethics and Regulation Physiology 8 works
- 2 Traditional Chinese Medicine Studies Complementary and alternative medicine 8 works
- 3 Quality and Safety in Healthcare Medical Laboratory Technology 6 works
- 4 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 5 works
- 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 5 works
- 6 Peptidase Inhibition and Analysis Oncology 5 works
- 7 Analytical Chemistry and Chromatography Spectroscopy 4 works
- 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 9 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 4 works
- 10 Bone Tissue Engineering Materials Biomedical Engineering 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Medical Products Administration's research output changed?
Output in 2018–2022 was 124% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beijing
- Chinese Academy of Sciences
- Tsinghua University
- Peking University
- University of Chinese Academy of Sciences
- Beihang University
- Beijing Institute of Technology
- Chinese Academy of Medical Sciences & Peking Union Medical College
- North China Electric Power University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.